资讯

FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...
Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial. Previous data showed that in the phase 3 JAVELIN ...
Real-life cancer survivor story: A 50-year-old resident of Cheshire, who mistook his initial symptoms of bladder cancer to be a UTI, drank cranberry juice as a possible treatment after being diagnosed ...
Johnson & Johnson's confidence in its bladder cancer therapy TAR-200 – dented by a negative phase 3 readout last year – seems to be justified. New data from the SunRISe-1 study of TAR-200 in ...
A cystectomy is a surgery to remove your bladder. The bladder can stretch or relax to hold about 2 cups of urine (pee). Cystectomy often treats bladder cancer. But bladder removal surgery can help ...
A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...
2 TAR-200 delivers sustained medication directly into the bladder and, in a pre-clinical setting, has been shown to allow for depth of penetration across bladder tissue layers.3 "Patients with ...
Nature showcases diverse nervous systems beyond a single command center. Several animals, including octopuses, leeches, and starfish, have evolved multiple brain-like organs or distributed nerve ...
Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...
The following is a summary of “Association between enlarged genital hiatus and prolapse with overactive bladder 1 year after vaginal delivery,” published in the April 2025 issue of American Journal of ...
Over the last years, many biological markers emerged that act as an adjunct for the detection of early bladder cancer recurrence. Some of these markers had a proven better sensitivity and ...